Among the various peptide therapy protocols used in functional medicine and anti-aging clinics, the combination of CJC-1295 and Ipamorelin has emerged as perhaps the most popular approach to optimizing growth hormone secretion. When stacked together, these two peptides work through complementary mechanisms to produce a more complete and sustained growth hormone response than either alone. MultiGen Wellness incorporates CJC-1295/Ipamorelin into our longevity and performance optimization programs.
Understanding the Mechanism — Two Pathways, One Goal
Growth hormone (GH) secretion from the pituitary is regulated by two opposing hypothalamic hormones: GHRH (growth hormone-releasing hormone), which stimulates GH release, and somatostatin, which inhibits it. CJC-1295 and Ipamorelin each work on different aspects of this system:
- CJC-1295 (with DAC): A synthetic GHRH analog that binds to GHRH receptors on pituitary cells, stimulating GH synthesis and release. The “with DAC” version includes a drug affinity complex that extends its half-life from minutes to several days, providing sustained GHRH signaling rather than a brief pulse. This results in elevated baseline IGF-1 over time without requiring daily injections.
- Ipamorelin: A selective growth hormone secretagogue that binds to ghrelin receptors in the pituitary, triggering GH release through the ghrelin/GHS-R pathway — a completely different mechanism than CJC-1295. Importantly, Ipamorelin is highly selective: it stimulates GH without significantly raising cortisol or prolactin, side effects seen with some other GH secretagogues.
By stimulating GH release through two distinct pathways simultaneously — and without triggering the somatostatin inhibitory response strongly — the combination produces a stronger, more physiological GH pulse than either peptide alone.
What Results to Expect
Most patients notice improved sleep depth within the first 1–2 weeks of CJC-1295/Ipamorelin therapy. Over 3–6 months of consistent use, benefits typically include: improved body composition (fat loss, muscle gains), faster recovery from exercise and injury, improved skin quality and hydration, increased energy and mental clarity, and enhanced libido. Lab measurements of IGF-1 are used to confirm and monitor GH axis activation.
Administration Protocol
The combination is typically administered via small subcutaneous injections before bedtime, when the natural GH pulse is most robust. Our physicians determine appropriate dosing based on your baseline IGF-1 and treatment goals, and monitor response through regular lab testing.
Now Serving Sugar Land, TX
MultiGen Wellness brings this same peptide therapy care to patients throughout Sugar Land and the surrounding TX area. Through our online platform, Sugar Land residents can complete lab work locally, meet with a licensed physician by telehealth, and start a personalized treatment plan without ever visiting an office in person.
Ready to optimize your growth hormone axis? Call (800) 259-0015 or schedule your free consultation with MultiGen Wellness’s peptide therapy specialists.